Fosun Pharma buys back 1,041,674 shares

Shanghai Fosun Pharmaceutical Group (SSE:600196) has filed a Next Day Disclosure Report indicating a buyback of company shares. On April 14, 2025, the company repurchased 1,041,674 ordinary shares on the Shanghai Stock Exchange, to be held as inventory shares. The prices paid ranged from RMB 23.93 to RMB 24.03 per share, resulting in a total cost of RMB 24,996,349.04. The repurchase represents 0.05% of the existing issued shares. Following the repurchase, the total number of issued shares (excluding inventory shares) stands at 2,108,344,213, and the total number of inventory shares is 11,041,752. The announcement was made by Director Wu Yifang.